Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews

Kafil Tahir S.; Nguyen Tran M.; MacDonald John K.; Chande Nilesh

首页> 外文期刊>Inflammatory bowel diseases >Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews

【24h】

Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews

机译：大麻用于治疗Crohn病和溃疡性结肠炎：来自Cochrane评论的证据

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: We systematically reviewed the safety and effectiveness of cannabis and cannabinoids treatment for Crohn's disease (CD) and ulcerative colitis (UC).

机译：背景：我们系统地审查了大麻和大麻素治疗克罗恩病（CD）和溃疡性结肠炎（UC）的安全性和有效性。

著录项

来源
《Inflammatory bowel diseases》 |2020年第4期|共8页
作者
Kafil Tahir S.; Nguyen Tran M.; MacDonald John K.; Chande Nilesh;
展开▼
作者单位

Western Univ Dept Med London ON Canada;

Robarts Clin Trials Inc London ON Canada;

Western Univ Dept Med London ON Canada;

Western Univ Div Gastroenterol London ON Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
cannabis; cannabinoids; Crohn's disease; ulcerative colitis; inflammatory bowel disease;

机译：大麻;大麻素;克罗恩病;溃疡性结肠炎;炎症性肠病;

相似文献

外文文献
中文文献
专利

1. Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews [J] . Kafil Tahir S., Nguyen Tran M., MacDonald John K., Inflammatory bowel diseases . 2020,第4期

机译：大麻用于治疗Crohn病和溃疡性结肠炎：来自Cochrane评论的证据
2. Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review [J] . Ulf Helwig, Michael Mross, Stefan Schubert, BMC Gastroenterology . 2020,第1期

机译：Vedolizumab和抗肿瘤坏死因子α治疗溃疡性结肠炎和克罗恩病患者的现实世界临床疗效和安全性：德国回顾性图表
3. Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn's disease: a systematic review and clinician surveys [J] . Gordon Jason P., McEwan Phil C., Maguire Andy, European journal of gastroenterology and hepatology . 2015,第7期

机译：表征溃疡性结肠炎和克罗恩病患者未满足的医疗需求以及新的生物治疗方法的潜在作用：系统评价和临床医生调查
4. Analysis of integrated inflammatory bowel disease mouse models to assess their disease driving pathways and relevance for Crohn’s disease and Ulcerative colitis [C] . Weiwei Schultz, Calixte Monast, Mathias Hesse, IEEE International Conference on Bioinformatics and Biomedicine . 2018

机译：分析综合性炎症性肠病小鼠模型以评估其疾病驱动途径以及与克罗恩病和溃疡性结肠炎的相关性
5. Epigenetics of Crohn's Disease, Ulcerative Colitis, and Phenotypically Normal Individuals [D] . Phillips, Delisa L. 2017

机译：克罗恩病，溃疡性结肠炎和表型正常个体的表观遗传
6. Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review [O] . Ulf Helwig, Michael Mross, Stefan Schubert, 2020

机译：Vedolizumab和抗肿瘤坏死因子α治疗溃疡性结肠炎和克罗恩病患者的现实世界临床疗效和安全性：德国回顾性图表
7. P778 Real-world drug treatment costs for ulcerative colitis and Crohn’s disease patients treated with vedolizumab vs. anti-TNFα: Results from a German retrospective chart review study [O] . S Campbell-Hill, D Stein, M Soni, 2018

机译：P778溃疡性结肠炎的真实世界药物治疗成本和患有vedolizumab对抗TNFα治疗的患者的溃疡性疾病患者：德国回顾性图表研究的结果

Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews

摘要

著录项

相似文献

相关主题

期刊订阅